74 related articles for article (PubMed ID: 27034954)
1. Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice.
Song W; Yan X; Zhai Y; Ren J; Wu T; Guo H; Song Y; Li X; Guo Y
PLoS One; 2023; 18(11):e0294363. PubMed ID: 37971986
[TBL] [Abstract][Full Text] [Related]
2. An anticonvulsive drug, valproic acid (valproate), has effects on the biosynthesis of fatty acids and polyketides in microorganisms.
Poolchanuan P; Unagul P; Thongnest S; Wiyakrutta S; Ngamrojanavanich N; Mahidol C; Ruchirawat S; Kittakoop P
Sci Rep; 2020 Jun; 10(1):9300. PubMed ID: 32518288
[TBL] [Abstract][Full Text] [Related]
3. Analysis of gene expression changes during lipid droplet formation in HepG2 human liver cancer cells.
Chiba M; Ohsugi Y; Matsumoto K; Tayama C
Med Int (Lond); 2024; 4(1):7. PubMed ID: 38283130
[TBL] [Abstract][Full Text] [Related]
4. Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of the human liver.
Chowdhury RR; Grosso MF; Gadara DC; Spáčil Z; Vidová V; Sovadinová I; Babica P
Chem Biol Interact; 2024 May; 397():111046. PubMed ID: 38735451
[TBL] [Abstract][Full Text] [Related]
5. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
Bai X; Hong W; Cai P; Chen Y; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
Toxicol Appl Pharmacol; 2017 Jun; 324():12-25. PubMed ID: 28366540
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
[TBL] [Abstract][Full Text] [Related]
7. Plin2-deficiency reduces lipophagy and results in increased lipid accumulation in the heart.
Mardani I; Tomas Dalen K; Drevinge C; Miljanovic A; Ståhlman M; Klevstig M; Scharin Täng M; Fogelstrand P; Levin M; Ekstrand M; Nair S; Redfors B; Omerovic E; Andersson L; Kimmel AR; Borén J; Levin MC
Sci Rep; 2019 May; 9(1):6909. PubMed ID: 31061399
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
Ma L; Wang Y; Chen X; Zhao L; Guo Y
Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
[TBL] [Abstract][Full Text] [Related]
9. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
10. Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence.
Pirozzi C; Lama A; Annunziata C; Cavaliere G; De Caro C; Citraro R; Russo E; Tallarico M; Iannone M; Ferrante MC; Mollica MP; Mattace Raso G; De Sarro G; Calignano A; Meli R
FASEB J; 2020 Jan; 34(1):676-690. PubMed ID: 31914696
[TBL] [Abstract][Full Text] [Related]
11. Valproate-Induced Metabolic Syndrome.
Shnayder NA; Grechkina VV; Trefilova VV; Efremov IS; Dontceva EA; Narodova EA; Petrova MM; Soloveva IA; Tepnadze LE; Reznichenko PA; Al-Zamil M; Altynbekova GI; Strelnik AI; Nasyrova RF
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239168
[TBL] [Abstract][Full Text] [Related]
12. Pepsin-digested chicken-liver hydrolysate attenuates hepatosteatosis by relieving hepatic and peripheral insulin resistance in long-term high-fat dietary habit.
Wu YS; Lin YL; Yang WY; Wang SY; Chen YC
J Food Drug Anal; 2021 Jun; 29(2):375-388. PubMed ID: 35696203
[TBL] [Abstract][Full Text] [Related]
13. Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer.
Yoshikawa K; Ishida M; Yanai H; Tsuta K; Sekimoto M; Sugie T
Mol Clin Oncol; 2022 Apr; 16(4):80. PubMed ID: 35251631
[TBL] [Abstract][Full Text] [Related]
14. Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach.
Alarcan J; de Sousa G; Katsanou ES; Spyropoulou A; Batakis P; Machera K; Rahmani R; Lampen A; Braeuning A; Lichtenstein D
Arch Toxicol; 2022 Jan; 96(1):211-229. PubMed ID: 34778935
[TBL] [Abstract][Full Text] [Related]
15. Effect of levetiracetam drug on antioxidant and liver enzymes in epileptic patients: case-control study.
Mahdavi A; Naeini AA; Najafi M; Maracy M; Ghazvini MA
Afr Health Sci; 2020 Jun; 20(2):984-990. PubMed ID: 33163067
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients.
Bai X; Xu C; Wen D; Chen Y; Li H; Wang X; Zhou L; Huang M; Jin J
Psychopharmacology (Berl); 2018 Sep; 235(9):2665-2673. PubMed ID: 29984389
[TBL] [Abstract][Full Text] [Related]
17. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
Hadzagic-Catibusic F; Hasanbegovic E; Melunovic M; Zubcevic S; Uzicanin S
Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of fennel oil extract against sodium valproate-induced hepatorenal damage in albino rats.
Al-Amoudi WM
Saudi J Biol Sci; 2017 May; 24(4):915-924. PubMed ID: 28490965
[No Abstract] [Full Text] [Related]
19. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
